Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Fosaprepitant Dimeglumine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 20,819Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Dr. Reddy's Laboratories

    02 1Supriya Lifescience

    03 2AFT Pharmaceuticals

    04 4Accord healthcare

    05 1Apotex Inc

    06 1Aspiro Pharma

    07 1Aurobindo Pharma Limited

    08 1Baxter Healthcare Corporation

    09 2Biological E

    10 1Chia Tai Tianqing Pharmaceutical Group

    11 1Cipla Medpro South Africa

    12 1Etico Lifesciences

    13 1Fresenius Kabi USA

    14 1GENEYORK PHARMS

    15 1Grupo Azevedos

    16 1Hikma Pharmaceuticals

    17 1JUNO PHARMACEUTICALS CORP.

    18 1Juno Pharma SA (Pty) Ltd

    19 1Lupin Ltd

    20 1MERCK CANADA INC

    21 2MSD INTL GMBH

    22 1MSN Laboratories

    23 2Medsurge Healthcare

    24 7Merck & Co

    25 1Naprod Life Sciences

    26 1Navinta

    27 1Piramal Enterprises Limited

    28 1Polifarma

    29 1Praxgen

    30 1Qilu Pharmaceutical

    31 2Reach Pharmaceuticals

    32 1Sagent Pharmaceuticals

    33 1Sakar Healthcare

    34 1Sandoz B2B

    35 1Steriscience

    36 1Tarbis Farma Sl

    37 2Tecnimede

    38 1Teva Pharmaceutical Industries

    39 1TherDose Pharma

    40 2Viatris

    41 1Zentiva

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI WW Frankfurt
    Booth #9.1B48
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2020-12-09

    Application Number : 211160

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Supriya Lifescience

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Fosaprepitant

    Brand Name :

    Dosage Form : Injection

    Dosage Strength : 150MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    Supriya

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Accord healthcare

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Accord healthcare

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2020-08-26

    Application Number : 204025

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Apotex Inc

    Canada
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 205020

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Aurobindo Pharma Limited

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2021-01-12

    Application Number : 210625

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Baxter Healthcare Corporation

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Baxter Healthcare Corporation

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 211860

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Biological E

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Biological E

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 212309

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Chia Tai Tianqing Pharmaceutical Gr...

    China
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Chia Tai Tianqing Pharmaceutical Gr...

    China
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2021-03-03

    Application Number : 212143

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Fresenius Kabi USA

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Fresenius Kabi USA

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2016-06-09

    Application Number : 206197

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Lupin Ltd

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Lupin Ltd

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 210689

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Merck & Co

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Merck & Co

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : EMEND

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2008-01-25

    Application Number : 22023

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Merck & Co

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Merck & Co

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : EMEND

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2010-11-12

    Application Number : 22023

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    MSN Laboratories

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    MSN Laboratories

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 209965

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Navinta

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Navinta

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2020-08-20

    Application Number : 212957

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Sagent Pharmaceuticals

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Sagent Pharmaceuticals

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : UNKNOWN

    Dosage Strength : UNKNOWN

    Packaging :

    Approval Date :

    Application Number : 204845

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Sandoz B2B

    Switzerland
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Sandoz B2B

    Switzerland
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2020-12-08

    Application Number : 203939

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Teva Pharmaceutical Industries

    Israel
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 210064

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Viatris

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 115MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 204015

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Viatris

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 204015

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    GENEYORK PHARMS

    Country
    Aus. Peptide Conference
    Not Confirmed
    arrow

    GENEYORK PHARMS

    Country
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    FOSAPREPITANT DIMEGLUMINE

    Brand Name : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER;INTRAVENOUS

    Dosage Strength : EQ 150MG BASE/VIAL

    Packaging :

    Approval Date : 2019-09-05

    Application Number : 211624

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF